What is Seaport Res Ptn's Estimate for Innospec Q1 Earnings?

Innospec Inc. (NASDAQ:IOSP - Free Report) - Equities research analysts at Seaport Res Ptn issued their Q1 2026 earnings per share estimates for shares of Innospec in a report issued on Tuesday, February 18th. Seaport Res Ptn analyst M. Harrison expects that the specialty chemicals company will earn $1.66 per share for the quarter. The consensus estimate for Innospec's current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec's Q2 2026 earnings at $1.68 EPS, Q3 2026 earnings at $1.76 EPS and Q4 2026 earnings at $1.86 EPS.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The firm had revenue of $466.80 million during the quarter, compared to analyst estimates of $447.43 million.

Separately, StockNews.com downgraded Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.

Innospec Stock Up 0.3 %

IOSP traded up $0.31 on Thursday, hitting $103.46. The company's stock had a trading volume of 281,005 shares, compared to its average volume of 130,141. Innospec has a 12 month low of $99.49 and a 12 month high of $133.71. The firm has a market cap of $2.58 billion, a P/E ratio of 72.86 and a beta of 1.09. The company's 50 day simple moving average is $110.87 and its 200-day simple moving average is $112.43.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. US Bancorp DE lifted its holdings in shares of Innospec by 323.6% in the third quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company's stock worth $621,000 after buying an additional 4,194 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Innospec by 3.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 336,522 shares of the specialty chemicals company's stock worth $38,057,000 after acquiring an additional 11,479 shares during the period. JPMorgan Chase & Co. lifted its stake in Innospec by 24.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company's stock worth $30,160,000 after purchasing an additional 52,640 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Innospec by 5.2% in the 3rd quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company's stock valued at $350,000 after purchasing an additional 154 shares during the period. Finally, Citigroup Inc. grew its position in shares of Innospec by 46.1% during the 3rd quarter. Citigroup Inc. now owns 32,193 shares of the specialty chemicals company's stock valued at $3,641,000 after purchasing an additional 10,162 shares in the last quarter. Institutional investors own 96.64% of the company's stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.